An Understanding

At Memorial Sloan Kettering Cancer Center, biopsies from patients now head to a new lab where they are examined to determine whether they house any of 341 genetic mutations, Bloomberg reports. Knowing whether the tumor harbors any of these changes can help guide the patient's treatment, it adds.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Related Posts

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.

Hong Kong is using DNA phenotyping to shame litterers.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.